Abbott Focuses On Improving Early Diagnosis Of Vascular Disease To Improve Outcomes

Nick West, chief medical officer for Abbott’s vascular business talked to Medtech Insight about Abbott’s efforts to improve the assessment and treatment of vascular disease long before patients need an intervention.

• Source: Alamy

To improve outcomes for patients with vascular disease, patients need accurate diagnoses and coordinated care early in their “patient journey,” Abbott concluded in its latest Beyond Intervention report.

“We can raise awareness about some of the gaps in patient care, and hopefully drive some positive change for the entirety of the industry,” Nick West, chief medical officer for Abbott’s vascular business, told Medtech

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cardiology

More from Device Area